Demonstration of EGFR gene copy loss in colorectal carcinomas by fluorescence in situ hybridization (FISH): a surrogate marker for sensitivity to specific anti‐EGFR therapy?

作者: T Sauer , M G Guren , T Noren , S Dueland

DOI: 10.1111/J.1365-2559.2005.02252.X

关键词:

摘要: … Conflicting results have been published regarding the expression of HER2 in colorectal cancer … Our results suggest that a treatment targeting HER2 is not an option in most rectal cancer …

参考文章(16)
A H Arnaout, P M Dawson, S Soomro, P Taylor, N A Theodorou, M Feldmann, B M Fendly, H M Shepard, S Shousha, HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies. Journal of Clinical Pathology. ,vol. 45, pp. 726- 727 ,(1992) , 10.1136/JCP.45.8.726
Christian Kersting, Nicola Tidow, Hartmut Schmidt, Cornelia Liedtke, Joerg Neumann, Werner Boecker, Paul J van Diest, Burkhard Brandt, Horst Buerger, Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma Laboratory Investigation. ,vol. 84, pp. 582- 587 ,(2004) , 10.1038/LABINVEST.3700077
G Speer, K Cseh, G Winkler, I Takács, Z Nagy, P Lakatos, Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers European Journal of Cancer. ,vol. 37, pp. 1463- 1468 ,(2001) , 10.1016/S0959-8049(01)00139-3
Montserrat Cotrina, Maria Buti, Rosendo Jardi, Josep Quer, Francisco Rodriguez, Carles Pascual, Rafael Esteban, Jaime Guardia, Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia) Journal of Hepatology. ,vol. 28, pp. 971- 977 ,(1998) , 10.1016/S0168-8278(98)80345-0
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
R.I Nicholson, J.M.W Gee, M.E Harper, EGFR and cancer prognosis. European Journal of Cancer. ,vol. 37, pp. 9- 15 ,(2001) , 10.1016/S0959-8049(01)00231-3
Akishi Ooi, Takuo Takehana, Xiaoling Li, Shioto Suzuki, Kazuyoshi Kunitomo, Hiroshi Iino, Hideki Fujii, Yasuhisa Takeda, Yoh Dobashi, Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study Modern Pathology. ,vol. 17, pp. 895- 904 ,(2004) , 10.1038/MODPATHOL.3800137
S Kapitanovic, S Radosevic, M Kapitanovic, S Andelinovic, Z Ferencic, M Tavassoli, D Primorac, Z Sonicki, S Spaventi, K Pavelic, R Spaventi, The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. Gastroenterology. ,vol. 112, pp. 1103- 1113 ,(1997) , 10.1016/S0016-5085(97)70120-3
Y. Hirono, K. Tsugawa, S. Fushida, I. Ninomiya, Y. Yonemura, I. Miyazaki, Y. Endou, M. Tanaka, T. Sasaki, Amplification of Epidermal Growth Factor Receptor Gene and Its Relationship to Survival in Human Gastric Cancer Oncology. ,vol. 52, pp. 182- 188 ,(1995) , 10.1159/000227455